Johnson & Johnson has announced the introduction of the VARIPULSE Plus Platform and the full commercial release of the NUVISION NAV Ultrasound Catheter at the 31st Annual AF Symposium. The company will present eleven accepted abstracts, including a Late Breaker presentation of the OMNY-AF Pilot study, featuring new clinical evidence and real-world safety and efficiency data for the VARIPULSE Platform. The NUVISION NAV Ultrasound Catheter is described as the world's first 4D intracardiac imaging catheter fully integrated with a 3D electroanatomical mapping system, designed to enhance anatomical visualization and guide complex electrophysiology procedures. The results from these studies and innovations will be presented at the symposium.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein.